Clinical Trials Logo
  1. Home
  2. Laryngeal Neoplasms
  3. NCT02430675

Irreversible Electroporation(IRE) For Unresectable Laryngeal Neoplasms — IRE  

Laryngeal Neoplasms Clinical Trial

Official title:
Irreversible Electroporation(IRE) For Unresectable Laryngeal Neoplasms: Phase I and Phase II Clinical Trial

Clinical Trial Summary

The purpose of this study is to evaluate the safety and efficacy of irreversible electroporation (IRE) for unresectable Laryngeal Neoplasms.

Clinical Trial Description

By enrolling patients with unresectable Laryngeal Neoplasms adapted to enrolled criteria, this study will document for the first time the safety and the short and long term efficacy of percutaneous IRE for unresectable Laryngeal Neoplasms. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02430675
Study type Interventional
Source Fuda Cancer Hospital, Guangzhou
Contact
Status Completed
Phase N/A
Start date January 1, 2015
Completion date January 1, 2021
View Details
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05406024 - Feasibility Study CORPPS
Terminated NCT00721539 - Assessing the da Vinci® Robotic Surgical System for Surgery of the Upper Aerodigestive Tract N/A
Completed NCT00534729 - Organ Preservation: Weekly Carboplatin & Taxol w/Concurrent RT for Locally Advanced Laryngeal & Hypopharyngeal CA N/A
Terminated NCT01216020 - Cetuximab Plus Radiotherapy Versus Cisplatin Plus Radiotherapy in Locally Advanced Head and Neck Cancer Phase 2
Recruiting NCT06227039 - Patient Augmented Reality and Vibratory Array Otorhinolaryngology Procedures N/A
Recruiting NCT03392220 - A Multicenter, Randomized, Case-control Study of Unilateral vs Bilateral Neck Dissection for cN0 Supraglottic Laryngeal Cancer N/A
Not yet recruiting NCT06137378 - European Larynx Organ Preservation Study (ELOS) [MK-3475-C44] Phase 2
Completed NCT00127465 - Investigating the Impact of Tailored Reports on Anxiety Amongst Cancer Patients and Their Confidants Phase 1/Phase 2
Terminated NCT02633540 - Investigation of Contralateral Arytenoid Sparing IMRT for T1a & T2a Larynx Cancer & Analysis of Post-treatment Laryngeal Function Phase 2
Terminated NCT00941135 - Safety and Efficacy Study in Patients With Local Advanced Larynx/Hypolarynx Carcinoma Treated With TPF Induction Chemotherapy Followed by Hyperfractionated Radiotherapy With Cetuximab Phase 2
Recruiting NCT05768178 - DETERMINE Trial Treatment Arm 05: Vemurafenib in Combination With Cobimetinib in Adult Patients With BRAF Positive Cancers. Phase 2/Phase 3
Completed NCT00721799 - F-18 Fluorothymidine PET Imaging for Early Evaluation of Response to Therapy in Head & Neck Cancer Patients Phase 2
Enrolling by invitation NCT01171235 - Study of Biomarker From Blood and Tissue of Head and Neck Carcinoma N/A
Terminated NCT00965003 - MRI Laryngeal Imaging With a Surface Coil Early Phase 1
Recruiting NCT02672904 - KTP vs CO2 Laser for the Treatment of Laryngeal Carcinoma N/A
Recruiting NCT04278638 - IORT in Local Advanced Laryngocarcinoma N/A
Completed NCT03585075 - Characterization of the Autofluorescence of Healthy and Pathological Tissues of Vocal Cords
Completed NCT00576134 - The Objective is to Respond to Patients' Needs in the Field of Larynx Replacement Phase 1
Completed NCT03010813 - A Novel Robotic System for Single Port and Natural Orifice Transluminal Endoscopic Surgery N/A
Recruiting NCT00396617 - Voice Prosthesis Made in Porous Titanium After Total Laryngectomy or Pharyngolaryngectomy Phase 1